2024 Publications

Implications of the 2022 lung function update and GLI global reference equations among patients with interstitial lung disease. View article. 2024. Andrew Li, Alan Teoh, Lauren Troy, Ian Glaspole, Margaret L Wilsher, Sally de Boer, Jeremy Wrobel, Yuben P Moodley, Francis Thien, Henry Gallagher, Michelle Galbraith, Daniel C Chambers, John Mackintosh, Nicole Goh, Yet Hong Khor, Adrienne Edwards, Karen Royals, Christopher Grainge, Benjamin Kwan, Gregory Keir, Chong Ong, Paul Reynolds, Elizabeth Veitch, Gin Tsen Chai, Ziqin Ng, Geak Poh Tan, Dan Jackson, Tamera Corte, Helen Jo, Thorax. 

Cluster analysis of blood biomarkers to identify molecular patterns in pulmonary fibrosis: assessment of a multicentre, prospective, observational cohort with independent validation. View article. 2024. Hernan P Fainberg, Yuben Moodley, Isaac Triguero, Tamera J Corte, Jannie M B Sand, Diana J Leeming, et al. The Lancet Respiratory Medicine.

Steroid therapy in acute exacerbation of fibrotic interstitial lung disease. View article. 2024. Koshy K, Barnes H, Farrand E, Glaspole I. Respirology. 

Impact of Test Instructions on 6-min Walk Distance in Adults with Chronic Respiratory Disease: A Randomized Controlled Trial. View article. 2024. Mellerick C.R.; Burge A.T.; Hill C.J.; Cox N.S.; Bondarenko J.; Holland A.E. Journal of Cardiopulmonary Rehabilitation and Prevention.

Exertional Desaturation During the 6-Minute Walk Test vs Daily Life in People With Fibrotic Interstitial Lung Disease. View article. Hoffman M.; Burge A.T.; Wong N.; McDonald C.F.; Chambers D.C.; Glaspole I.; Mackintosh J.A.; Ekström M.; Sköld M.; Goh N.S.L.; Corte T.J.; Holland A.E. 2024. Chest.

Using change in 6-minute walk distance to predict survival in progressive pulmonary fibrosis: A promising measure in need of precision. View article. Holland A.E.; Dowman L. 2024. Respirology.

Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease. View article. Mackintosh J.A.; Chambers D.C. 2024. European Respiratory Journal.

Disease Behaviour Classification: A pragmatic model for predicting outcomes in Interstitial Lung Disease. View article. Harrison M.; Jo H.E.; Troy L.K.; Nguyen B.; Webster S.E.; Geis M.; Lai S.; Mulyadi E.; Cooper W.A.; Mahar A.; Teoh A.; Jee A.; Corte T.J. 2024. Respiratory Medicine.

Reply to: Optimal clinical practice in IPF and PPF: Integrating scientific ethos and clinical reasoning. View article. Mackintosh J.A.; Keir G.; Corte T.J. 2024. Respirology.

Editorial: Epidemiology and risk factors for interstitial lung diseases. View article. Jeganathan N.; Corte T.J.; Spagnolo P. 2024. Frontiers in Medicine.

Respiratory teletrials—A call for equitable access to clinical trials for people with respiratory conditions. View article. Holland A.E.; Woollett A.; Goh N.; Glaspole I. 2024. Respirology.

Drug-induced interstitial lung disease: a narrative review of a clinical conundrum. View article. Harrison M.; Kavanagh G.; Corte T.J.; Troy L.K. 2024. Expert Review of Respiratory Medicine.

Unravelling the health and economic burden of interstitial lung diseases in adults in Australia. View article. Cox I.A.; Graaff B.D.; Zheng Q.; Corte T.J.; Walters E.H.; Palmer A.J. 2024. Australian Journal of General Practice.

Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision. View article. Mackintosh J.A.; Keir G.; Troy L.K.; Holland A.E.; Grainge C.; Chambers D.C.; Sandford D.; Jo H.E.; Glaspole I.; Wilsher M.; Goh N.S.L.; Reynolds P.N.; Chapman S.; Mutsaers S.E.; de Boer S.; Webster S.; Moodley Y.; Corte T.J. 2024. Respirology.

Summary for Clinicians: Clinical Practice Guideline on Pulmonary Rehabilitation for Adults with Chronic Respiratory Disease. View article.  Jenkins A.R.; Cox N.S.; Tappan R.S.; Holland A.E.; Rochester C.L.; Alison J.A.; Carlin B.; Ruminjo J.K.; Thomson C.C. 2024. Annals of the American Thoracic Society.

Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis The Randomized Phase III STARSCAPE Trial. View article. Richeldi L.; Schiffman C.; Behr J.; Inoue Y.; Corte T.J.; Cottin V.; Jenkins R.G.; Nathan S.D.; Raghu G.; Walsh S.L.F.; Jayia P.K.; Kamath N.; Martinez F.J. 2024. American Journal of Respiratory and Critical Care Medicine.

A novel therapy for intractable chronic cough. View article. Bricknell M.; Zhao C.Z.-F.; Smallwood N.; Goh N. 2024. Respirology Case Reports.

High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study. View article. Desai S.R.; Sivarasan N.; Johannson K.A.; George P.M.; Culver D.A.; Devaraj A.; Lynch D.A.; Milne D.; Renzoni E.; Nunes H.; Sverzellati N.; Spagnolo P.; Baughman R.P.; Yadav R.; Piciucchi S.; Walsh S.L.F.; Kouranos V.; Wells A.U.; Anderson A.; Morgenthau A.; Gaser A.; Vizel A.; Speranskaya A.; Gerke A.; Goksel A.; Undurraga A.; Sharma A.; Oh A.; Leung A.; Larici A.R.; Prasse A.; Mazzei A.; Morais A.; Bhalla A.; Del Rio B.; Jankharia B.; Elicker B.; Pereira C.; Biegelman-Aubry C.; White C.; Ravaglia C.; Hsia C.; Schaefer-Prokop C.; Launay D.; Talwar D.; Castillo D.; Patel D.; Israel-Biet D.; Valeyre D.; Britt E.J.; Bargagli E.; Bendstrup E.; Crouser E.; Nossent E.; Shmelev E.; Porquera E.C.; Bonella F.; Cohen-Aubart F.; Jeny F.; Ferrara G.; Jin G.Y.; Robbie H.; Prosch H.; Sumikawa H.; Ling-Pei H.; Lee H.Y.; Strambu I.; Buendia-Roldan I.; Grutters J.; Ryu J.; Swigris J.; Miedema J.; Goo J.M.; Barnett J.; Verschakelen J.; Goldin J.; Seo J.B.; Enghelmayer J.; Mana J.; Behr J.; Patterson K.; Antoniou K.; Brown K.; Fujimoto K.; Savale L.; Maier L.; Richeldi L.; Neto M.L.R.; Humbert M.; Judson M.; Veltkamp M.; Wilsher M.; Molina M.; Otaola M.; Revel M.-P.; Silva M.; Drent M.; Schiebler M.; Wijsenbeek-Lourens M.; Bonifazi M.; Remy-Jardin M.; Koslow M.; Balter M.; Kreuter M.; Thillai M.; Hamzeh N.; Chaudhuri N.; Mogulkoc N.; Todd N.; Screaton N.; Goh N.; Shah N.; Obi O.; Shlobin O.; Baranova O.; Bresser P.; Rottoli P.; Brillet P.-Y.; Said-Hartley Q.; Borie R.; Mostard R.; van Zyl-smit R.; Kairalla R.; Egashira R.; Boussouar S.; Lee S.M.; Bhalla S.; Tomassetti S.; Quadrelli S.; Hart S.P.; Danoff S.; Rajan S.; Choi S.M.; Copley S.; Kim T.J.; Johkoh T.; Corte T.; McLoud T.; Wessendorf T.; Alfaro T.; Arai T.; Costabel U.; Vicens-Zygmunt V.; Poletti V.; Cottin V.; Vucinic V.; Wuyts W.; van Es W.; Jeong Y.J.; Inoue Y. 2024. The Lancet Respiratory Medicine.

Use of infection control measures in people with chronic lung disease: mixed methods study. View article. Jones A.W.; King B.E.; Cumella A.; Hopkinson N.S.; Hurst J.R.; Holland A.E. 2024. ERJ Open Research.

Treatable traits models of care. View article. McDonald V.M.; Holland A.E. 2024. Respirology.

Exploring the anti-inflammatory and anti-fibrotic activity of NFκB decoy oligodeoxynucleotide-loaded spermine-functionalized acetalated nanoparticles. View article. De Rubis G.; Chakraborty A.; Paudel K.R.; Wang C.; Kannaujiya V.; Wich P.; Hansbro P.M.; Samuel C.S.; Oliver B.; Dua K. 2024. Chemico-Biological Interactions.

Navigating the COVID-19 pandemic: Experiences and self-management approaches adopted by people with interstitial lung disease. View article. Tikellis G.; Corte T.; Glaspole I.N.; Goh N.S.L.; Khor Y.H.; Wrobel J.; Symons K.; Fuhrmeister L.; Glenn L.; Chirayath S.; Troy L.K.; King B.; Holland A.E. Chronic Respiratory Disease.

Mortality surrogates in combined pulmonary fibrosis and emphysema. View article. Zhao A.; Gudmundsson E.; Mogulkoc N.; van Moorsel C.; Corte T.J.; Vasudev P.; Romei C.; Chapman R.; Wallis T.J.M.; Denneny E.; Goos T.; Savas R.; Ahmed A.; Brereton C.J.; van Es H.W.; Jo H.; De Liperi A.; Duncan M.; Pontoppidan K.; De Sadeleer L.J.; van Beek F.; Barnett J.; Cross G.; Procter A.; Veltkamp M.; Hopkins P.; Moodley Y.; Taliani A.; Taylor M.; Verleden S.; Tavanti L.; Vermant M.; Nair A.; Stewart I.; Janes S.M.; Young A.L.; Barber D.; Alexander D.C.; Porter J.C.; Wells A.U.; Jones M.G.; Wuyts W.A.; Jacob J. 2024. European Respiratory Journal.

TGF-β1, pSmad-2/3, Smad-7, and β-Catenin Are Augmented in the Pulmonary Arteries from Patients with Idiopathic Pulmonary Fibrosis (IPF): Role in Driving Endothelial-to-Mesenchymal Transition (EndMT). View article. Archana Vijay Gaikwad, Mathew Suji Eapen, Surajit Dey, Prem Bhattarai, Affan Mahmood Shahzad, Collin Chia, Jade Jaffar, Glen Westall, Darren Sutherland, Gurpreet Kaur Singhera, Tillie-Louise Hackett, Wenying Lu and Sukhwinder Singh Sohal. 2024. Journal of Clinical Medicine.

Platelet Activating Factor Receptor and Intercellular Adhesion Molecule-1 Expression Increases in the Small Airway Epithelium and Parenchyma of Patients with Idiopathic Pulmonary Fibrosis: Implications for Microbial Pathogenesis. View article. Shahzad AM, Lu W, Dey S, Bhattarai P, Gaikwad AV, Jaffar J, Westall G, Sutherland D, Singhera GK, Hackett TL, Eapen MS, Sohal SS. 2024. Journal of Clinical Medicine.